Frontrunner to lead FDA, dogged by controversies, has developed knack for confronting them
WASHINGTON — Before he interviewed with President Trump last week to become Food and Drug Administration commissioner, Dr. Stephen Hahn had only been here once in a formal capacity: to apologize to Congress.
The veteran cancer researcher came to Capitol Hill in 2009 to take responsibility for years of botched care by a doctor under his supervision. Ninety-two U.S. military veterans had been implanted with radioactive “seeds,” meant to fight prostate cancer, at the wrong dose — or in the wrong organ entirely.
